Approach to the Patient: The Adult With Congenital Adrenal Hyperplasia
Open accessThe DOI matches its Crossref record; 69 of the 73 references it cites were found in a registry or an index.
Abstract
The most common form of congenital adrenal hyperplasia is steroid 21-hydroxylase deficiency (21OHD). When the nonclassical (mild) form is included, 21OHD is the most common genetic disease in human beings. With the advent of pharmaceutical preparation of glucocorticoids starting in the 1960s and newborn screening starting in the 1990s, the majority of children with 21OHD are reaching adulthood, which has yielded a cohort of patients with, in essence, a new disease. Only recently have some data emerged from cohorts of adults with 21OHD, and in some centers, experience with the management of these patients is growing. These patients suffer from poor health, infertility, characteristic tumors in the adrenal glands and gonads, and consequences of chronic glucocorticoid therapy. Their care is fragmented and inconsistent, and many stop taking their medications out of frustration. Internal medicine residents and endocrinology fellows receive little training in their care, which further discourages their seeking medical attention. Adults with 21OHD have a different physiology from patients with Addison's disease or other androgen excess states, and their needs are different than those of young children with 21OHD. Consequently, their care requires unorthodox treatment and monitoring strategies foreign to most endocrine practitioners. Our goal for this article is to review their physiology, complications, and needs in order to develop rational and effective treatment and monitoring strategies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The ratio of androstenedione to testosterone is ,0.5 in eugonadal men; values .2indicate poor CAH control with a significant fraction of testosterone of adrenal origin (228).”
From Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society* Clinical Practice Guideline (2018) · cites this paper as [228]
Citations
Cites
A Critical Evaluation of Simple Methods for the Estimation of Free Testosterone in Serum
Vermeulen, A., Verdonck, L., & Kaufman, J. M. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.10.6079 · Cited by 3,824 · cited 1×
“In women, total T and SHBG are used to determine free and bioavailable T by calculation (38, 39), and these values are the most important parameters to gauge androgen excess.”
Speiser, P. W., Azziz, R., Baskin, L. S., Ghizzoni, L., Hensle, T. W., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Montori, V. M., Oberfield, S. E., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2631 · Cited by 1,468 · cited 2×
“Dexamethasone use for prenatal treatment of affected fetuses with 21OHD has been employed but is considered experimental for these reasons (28).”
Congenital Adrenal Hyperplasia
(1987) · New England Journal of Medicine · doi:10.1056/nejm198711263172211 · Cited by 1,409
Congenital adrenal hyperplasia
Speiser, P. W., & White, P. C. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021561 · Cited by 1,405
Rosner, W., Auchus, R. J., Azziz, R., Sluss, P. M., & Raff, H. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1864 · Cited by 1,176 · cited 1×
“In women, total T and SHBG are used to determine free and bioavailable T by calculation (38, 39), and these values are the most important parameters to gauge androgen excess.”
Self-citationHigh frequency of nonclassical steroid 21-hydroxylase deficiency.
Speiser, P., Dupont, B., Rubinstein, P., Piazza, A., Kaštelan, A., & New, M. I. (1985) · PubMed Central · Cited by 528
High frequency of nonclassical steroid 21-hydroxylase deficiency
SPEISER, P. W., DUPONT, B. O., RUBINSTEIN, P., PIAZZA, A., KASTELAN, A., & NEW, M. I. (1986) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-198604000-00017 · Cited by 523
Health status of adults with congenital adrenal hyperplasia: a cohort study of 203 patients
Arlt, W., Willis, D. S., Wild, S. H., Krone, N., Doherty, E. J., Hahner, S., Han, T. S., Carroll, P. V., Conway, G. S., Rees, D. A., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0917 · Cited by 506 · cited 10×
“It is therefore important to avoid confusing TARTs with primary testicular tumors when discussing a case with the patient and colleagues from otherdisciplines.”
BackgroundInfluentialSelf-citation(2002) · Hormone Research in Paediatrics · doi:10.1159/000065490 · Cited by 458
Krone, N., Braun, A., Roscher, A. A., Knorr, D., & Schwarz, H. P. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.3.6441 · Cited by 397
Therrell, B. L., Berenbaum, S. A., Manter-Kapanke, V., Simmank, J., Korman, K., Prentice, L., Gonzalez, J., & Gunn, S. (1998) · Pediatrics · doi:10.1542/peds.101.4.583 · Cited by 344 · cited 1×
“Whereas virtually all patients with classic 21OHD are ascertained as children, primarily in the first year of life and now often by newborn screening (2), nonclassic 21OHD is diagnosed occasionally in childhood or at newborn screening, most commonly in adolescence and young adulthood, and sometimes in adulthood.”
BackgroundJoint LWPES/ESPE CAH Working Group (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020611 · Cited by 332
Clinical characteristics of a cohort of 244 patients with congenital adrenal hyperplasia
Finkielstain, G. P., Kim, M. S., Sinaii, N., Nishitani, M., Van Ryzin, C., Hill, S. C., Reynolds, J. C., Hanna, R. M., & Merke, D. P. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2102 · Cited by 313
Genetics of congenital adrenal hyperplasia
Krone, N., & Arlt, W. (2009) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2008.10.014 · Cited by 312
Self-citationBarnes, R. B., Rosenfield, R. L., Ehrmann, D. A., Cara, J. F., Cuttler, L., Levitsky, L. L., & Rosenthal, I. M. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.5.7962325 · Cited by 304 · cited 3×
“Women with 21OHD often develop a secondary polycystic ovary syndrome with ovarian androgen excess (40); consequently, menstrual irregularity and elevated androgens do not always indicate poor control.”
BackgroundNordenskjöld, A., Holmdahl, G., Frisén, L., Falhammar, H., Filipsson, H., Thorén, M., Janson, P. O., & Hagenfeldt, K. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0556 · Cited by 205 · cited 1×
“Most women with classic 21OHD never attempt pregnancy, for many reasons, including vaginal stenosis (59) and dyspareunia (60).”
BackgroundLong Term Outcome in Adult Males with Classic Congenital Adrenal Hyperplasia1
Cabrera, M. S., Vogiatzi, M. G., & New, M. I. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.7.7668 · Cited by 204
Fertility in women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency
Bidet, M., Bellanné-Chantelot, C., Galand-Portier, M.-B., Golmard, J.-L., Tardy, V., Morel, Y., Clauin, S., Coussieu, C., Boudou, P., Mowzowicz, I., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1383 · Cited by 204 · cited 1×
“Glucocorticoid therapy should be minimized to accomplish the goal for the requisite period of time, such as restoring fertility, and 1 retrospective series found better outcomes when hydrocortisone is continued until delivery (29).”
BackgroundOelkers, W., Diederich, S., & Bähr, V (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.75.1.1320051 · Cited by 193
Gastaud, F., Bouvattier, C., Duranteau, L., Brauner, R., Thibaud, E., Kutten, F., & Bougnères, P. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1757 · Cited by 192
Finkielstain, G. P., Chen, W., Mehta, S. P., Fujimura, F. K., Hanna, R. M., Van Ryzin, C., McDonnell, N. B., & Merke, D. P. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0319 · Cited by 192 · cited 1×
“In 1 study, 70% of patients with nonclassic 21OHD were compound heterozygotes and carriers for classic 21OHD (34).”
BackgroundMerke, D. P., Keil, M. F., Jones, J. V., Fields, J., Hill, S., & Cutler, G. B. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.3.6462 · Cited by 190
Casteràs, A., De Silva, P., Rumsby, G., & Conway, G. S. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03563.x · Cited by 190
Reproductive outcome of women with 21-hydroxylase-deficient nonclassic adrenal hyperplasia
Moran, C., Azziz, R., Weintrob, N., Witchel, S. F., Rohmer, V., Dewailly, D., Marcondes, J. A. M., Pugeat, M., Speiser, P. W., Pignatelli, D., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0062 · Cited by 174 · cited 1×
“The diagnosis and treatment of nonclassic CAH has been reviewed in detail elsewhere (30, 31).”
BackgroundHigh prevalence of reduced fecundity in men with congenital adrenal hyperplasia
Reisch, N., Flade, L., Scherr, M., Rottenkolber, M., Pedrosa Gil, F., Bidlingmaier, M., Wolff, H., Schwarz, H.-P., Quinkler, M., Beuschlein, F., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1414 · Cited by 170 · cited 3×
“Male subfertility can also occur as the consequence of TART expansion (16, 20, 21).”
BackgroundFalhammar, H., Filipsson, H., Holmdahl, G., Janson, P.-O., Nordenskjöld, A., Hagenfeldt, K., & Thorén, M. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1350 · Cited by 167 · cited 3×
“Mineralocorticoid replacement In contrast to the salt-wasting tendency of all children withclassic21OHD,adolescents (8)andadults (6)withclassic 21OHD are prone to developing hypertension.”
BackgroundPhysiology and molecular genetics of 17β-hydroxysteroid dehydrogenases
Andersson, S., & Moghrabi, N. N. (1997) · Steroids · doi:10.1016/s0039-128x(96)00173-0 · Cited by 157
Fractures and bone mineral density in adult women with 21-hydroxylase deficiency
Falhammar, H., Filipsson, H., Holmdahl, G., Janson, P.-O., Nordenskjöld, A., Hagenfeldt, K., & Thorén, M. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0744 · Cited by 151 · cited 1×
“Several studieshaveshownreducedbonemineral density in adults with 21OHD (9, 10).”
Backgroundder Grinten, H. L. C., Otten, B. J., Hermus, A. R., Sweep, F. C. G. J., & de Kaa, C. A. H. (2007) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.03.051 · Cited by 143
Claahsen-van der Grinten, H. L., Otten, B. J., Takahashi, S., Meuleman, E. J. H., Hulsbergen-van de Kaa, C., Sweep, F. C. G. J., & Hermus, A. R. M. M. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1311 · Cited by 139 · cited 2×
“Surgical TART removal effectively treats the mass effect in the testes but has not been shown to improve fertility (45).”
BackgroundUse of autologous buccal mucosa for vaginoplasty: a study of eight cases
Lin, W.-C., Chang, C. Y. Y., Shen, Y. Y., & Tsai, H. D. (2003) · Human Reproduction · doi:10.1093/humrep/deg095 · Cited by 139
Frequency and causes of adrenal crises over lifetime in patients with 21-hydroxylase deficiency
Reisch, N., Willige, M., Kohn, D., Schwarz, H.-P., Allolio, B., Reincke, M., Quinkler, M., Hahner, S., & Beuschlein, F. (2012) · European Journal of Endocrinology · doi:10.1530/eje-12-0161 · Cited by 136
Krone, N., Rose, I. T., Willis, D. S., Hodson, J., Wild, S. H., Doherty, E. J., Hahner, S., Parajes, S., Stimson, R. H., Han, T. S., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3343 · Cited by 119 · cited 1×
“A recent cohort study in 153 patients found that impaired health status in adults with CAH did not correlate with genotype but was mostly acquired as a consequence of glucocorticoid treatment (33).”
BackgroundSelf-citationAvila, N. A., Premkumar, A., & Merke, D. P. (1999) · American Journal of Roentgenology · doi:10.2214/ajr.172.4.10587136 · Cited by 109
Stikkelbroeck, N. M. M. L., Beerendonk, C. C. M., Willemsen, W. N. P., Schreuders-Bais, C. A., Feitz, W. F. J., Rieu, P. N. M. A., Hermus, A. R., & Otten, B. J. (2003) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/s1083-3188(03)00155-4 · Cited by 107
Gleeson, H., Davis, J., Jones, J., O'Shea, E., & Clayton, P. E. (2013) · Clinical Endocrinology · doi:10.1111/cen.12053 · Cited by 103 · cited 1×
“appointments with the adult endocrinologist (23).”
Nermoen, I., Rørvik, J., Holmedal, S. H., Hykkerud, D. L., Fougner, K. J., Svartberg, J., Husebye, E. S., & Løvås, K. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04151.x · Cited by 103
Nonclassic Congenital Adrenal Hyperplasia
Witchel, S. F., & Azziz, R. (2010) · International Journal of Pediatric Endocrinology · doi:10.1155/2010/625105 · Cited by 101
der Grinten, H. L. C., Otten, B. J., Sweep, F. C. G. J., & Hermus, A. R. (2007) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.11.148 · Cited by 101
Reisch, N., Scherr, M., Flade, L., Bidlingmaier, M., Schwarz, H.-P., Müller-Lisse, U., Reincke, M., Quinkler, M., & Beuschlein, F. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1929 · Cited by 92
Chakhtoura, Z., Bachelot, A., Samara-Boustani, D., Ruiz, J.-C., Donadille, B., Dulon, J., Christin-Maître, S., Bouvattier, C., Raux-Demay, M.-C., Bouchard, P., et al. (2008) · European Journal of Endocrinology · doi:10.1530/eje-07-0887 · Cited by 90 · cited 1×
“In 1 study, bone mass correlated inversely with the cumulative dose of glucocorticoid (12).”
BackgroundCharmandari, E. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.10.4679 · Cited by 84
Ravichandran, R. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.5.1776 · Cited by 84
Lo, J. C., Schwitzgebel, V. M., Tyrrell, J. B., Fitzgerald, P. A., Kaplan, S. L., Conte, F. A., & Grumbach, M. M. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.3.5565 · Cited by 83
Sciannamblo, M., Russo, G., Cuccato, D., Chiumello, G., & Mora, S. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2823 · Cited by 82 · cited 1×
“Several studieshaveshownreducedbonemineral density in adults with 21OHD (9, 10).”
BackgroundNandagopal, R., Sinaii, N., Avila, N. A., Van Ryzin, C., Chen, W., Finkielstain, G. P., Mehta, S. P., McDonnell, N. B., & Merke, D. P. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0019 · Cited by 81 · cited 1×
“Among parents of children with classic 21OHD, 4% are affected with cryptic or undiagnosed nonclassic 21OHD (36).”
BackgroundLong Term Outcome in Adult Males With Classic Congenital Adrenal Hyperplasia
Jarow, J. P. (2002) · The Journal of Urology · doi:10.1097/00005392-200208000-00120 · Cited by 77
Lo, J. C.-M. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.3.930 · Cited by 73
Glucocorticoid treatment regimen and health outcomes in adults with congenital adrenal hyperplasia
Han, T. S., Stimson, R. H., Rees, D. A., Krone, N., Willis, D. S., Conway, G. S., Arlt, W., Walker, B. R., Ross, R. J., & (CaHASE), U. K. C. A. H. A. S. E. (2013) · Clinical Endocrinology · doi:10.1111/cen.12045 · Cited by 70
Self-citationAuchus, R., Witchel, S., Leight, K., Aisenberg, J., Azziz, R., Bachega, T., Baker, L., Baratz, A., Baskin, L., Berenbaum, S., et al. (2010) · International Journal of Pediatric Endocrinology · doi:10.1186/1687-9856-2010-275213 · Cited by 66
Self-citationTiosano, D., Vlodavsky, E., Filmar, S., Weiner, Z., Goldsher, D., & Bar-Shalom, R. (2010) · Hormone Research in Paediatrics · doi:10.1159/000295722 · Cited by 65 · cited 1×
“Even women with classic 21OHD can develop adrenal rest tumors in the pelvic area after bilateral adrenalectomy, with recurrent androgen excess (17, 18).”
BackgroundKhan, N., Sharma, K. K., Andersson, S., & Auchus, R. J. (2004) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2004.05.023 · Cited by 60
Self-citationSircili, M. H. P., Mendonca, B. B. D., Denes, F. T., Madureira, G., Bachega, T. A. S. S., & Queiroz e Silva, F. A. D. (2006) · Clinics · doi:10.1590/s1807-59322006000300005 · Cited by 57
Outcome of bilateral adrenalectomy in congenital adrenal hyperplasia: one unit’s experience
Ogilvie, C. M., Rumsby, G., Kurzawinski, T., & Conway, G. S. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02096 · Cited by 55 · cited 1×
“Unilateral or bilateral adrenalectomy has been employed to restore fertility in otherwise compliant men (56) and women (57) with classic 21OHD, respectively.”
Godbout, A., Tejedor, I., Malivoir, S., Polak, M., & Touraine, P. (2012) · Hormone Research in Paediatrics · doi:10.1159/000343818 · Cited by 51
Crocker, M. K., Barak, S., Millo, C. M., Beall, S. A., Niyyati, M., Chang, R., Avila, N. A., Van Ryzin, C., Segars, J., Quezado, M., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2298 · Cited by 48 · cited 1×
“Even women with classic 21OHD can develop adrenal rest tumors in the pelvic area after bilateral adrenalectomy, with recurrent androgen excess (17, 18).”
BackgroundCaldato, M. C. F., Fernandes, V. T., & Kater, C. E. (2004) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302004000500017 · Cited by 48
Amenorrhea related to progestin excess in congenital adrenal hyperplasia.
Rl, R., Bickel, S., & Ak, R. (1980) · PubMed · Cited by 43
Kim, M., & Merke, D. (2009) · Seminars in Reproductive Medicine · doi:10.1055/s-0029-1225259 · Cited by 41
Observation of hypertension in children with 21-hydroxylase deficiency: A preliminary report
Nebesio, T. D., & Eugster, E. A. (2006) · Endocrine · doi:10.1007/s12020-006-0005-4 · Cited by 39
Giant Bilateral Myelolipomas in a Man with Congenital Adrenal Hyperplasia
McGeoch, S. C., Olson, S., Krukowski, Z. H., & Bevan, J. S. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2373 · Cited by 38
Tiitinen, A. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.6.2442 · Cited by 38
Autologous buccal mucosa vulvovaginoplasty for high urogenital sinus
Samuelson, M. L., & Baker, L. A. (2005) · Journal of Pediatric Urology · doi:10.1016/j.jpurol.2005.09.001 · Cited by 34
Rezvani, I., Garibaldi, L. R., Digeorge, A. M., & Artman, H. G. (1983) · Pediatric Research · doi:10.1203/00006450-198302000-00010 · Cited by 33
Winterer, J., Chrousos, G. P., Loriaux, D. L., & Cutler, G. B. (1985) · The Journal of Pediatrics · doi:10.1016/s0022-3476(85)80486-8 · Cited by 31
Mouritsen, A., Juul, A., & Jørgensen, N. (2010) · International Journal of Andrology · doi:10.1111/j.1365-2605.2009.00958.x · Cited by 30
Prevalence of Testicular Adrenal Rest Tissue in Neonates
Bouman, A., Hulsbergen-van de Kaa, C., & Claahsen-van der Grinten, H. L. (2011) · Hormone Research in Paediatrics · doi:10.1159/000316531 · Cited by 29
Winterer, J., Chrousos, G. P., Loriaux, D. L., & Cutler, G. B. (1985) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1985.tb14603.x · Cited by 14
Scaroni, C., Favia, G., Lumachi, F., Opocher, G., Bonanni, G., Mantero, F., & Armanini, D. (2003) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-2003-37499 · Cited by 13
Cited by
Speiser, P. W., Arlt, W., Auchus, R. J., Baskin, L. S., Conway, G. S., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Murad, M. H., Oberfield, S. E., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01865 · Cited by 1,234
Self-citationCongenital adrenal hyperplasia
El-Maouche, D., Arlt, W., & Merke, D. P. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31431-9 · Cited by 669
Self-citationMallappa, A., Sinaii, N., Kumar, P., Whitaker, M. J., Daley, L.-A., Digweed, D., Eckland, D. J. A., Van Ryzin, C., Nieman, L. K., Arlt, W., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3809 · Cited by 167
“In addition to the lack of management consensus, it is difficult to achieve satisfactory outcome with conventional glucocorticoid formulations (6).”
BackgroundSelf-citationA new dawn for androgens: novel lessons from 11-oxygenated C19 steroids
Pretorius, E., Arlt, W., & Storbeck, K.-H. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.08.014 · Cited by 142
Self-citationJu, Q., Tao, T., Hu, T., Karadağ, A. S., Al-Khuzaei, S., & Chen, W. (2016) · Clinics in Dermatology · doi:10.1016/j.clindermatol.2016.10.004 · Cited by 140
Metadata
- Authors
- Auchus, R. J., & Arlt, W.
- Affiliations
- University of Michigan (US)
- University of Birmingham (GB)
- Corresponding author
- Auchus, Richard J.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2013-07-01
- Volume
- 98
- Issue
- 7
- Pages
- 2645-2655
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- PMC
- PMC3701266
- OpenAlex
- W2147891871
- Cited by
- 121
- References
- 73
- Citations by year
- 2026: 8 · 2025: 5 · 2024: 9 · 2023: 11 · 2022: 7 · 2021: 8 · 2020: 4 · 2019: 16 · 2018: 10 · 2017: 3 · 2016: 11 · 2015: 11 · 2014: 14 · 2013: 4
- FWCI
- 5.97
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Spiral (Imperial College London) (submittedVersion)
- Funders
- National Institute of General Medical Sciences (R01GM086596)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK020572)
- Janssen Pharmaceuticals
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Keywords
- congenital adrenal hyperplasia, 21-hydroxylase deficiency, adult patients, non-classical congenital adrenal hyperplasia, glucocorticoid therapy, infertility, adrenal tumors, gonadal tumors, disease management, patient monitoring, endocrinology training
- MeSH terms
- Adrenal Gland Neoplasms, Adrenal Hyperplasia, Congenital, Adult, Aging, Female, Humans, Infertility, Patient Acceptance of Health Care, Steroid 21-Hydroxylase, Precision Medicine, Transition to Adult Care
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.